帕金森病的抗精神病药物:通过网络元分析和试验顺序分析进行系统审查的协议
Johanne Juul Petersen1,2, Caroline Barkholt Kamp3, Sophie Juul3,4,5
1Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark johanne.juul.petersen@ctu.dk.
BMJ open
|September 26, 2025
概括
本系统性审查协议概述了对帕金森病精神病的抗精神病药物的评估. 它旨在评估这些药物的安全性和有效性,以控制精神病症状,同时考虑潜在的危害.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 帕金森病 (PD) 是一种进展性神经系统疾病,全球发病率不断增加.
- 帕金森病精神病 (PDP) 是一种常见的神经精神病并发症,通常用抗精神病药物治疗.
- 缺乏对PD患者抗精神病药物使用的全面评估.
研究的目的:
- 系统地审查抗精神病药物对帕金森病患者的有益和有害影响.
- 评估抗精神病药对精神病症状和患者整体幸福感的影响.
- 为在PD中使用抗精神病药物提供基于证据的指导.
主要方法:
- 关于随机临床试验系统审查的议定书.
- 在主要数据库和试验注册表中进行全面的文献搜索.
- 数据提取和偏差风险评估使用Cochrane 偏差风险工具-V.2.
- 通过综合,试验顺序和网络元分析来综合证据.
- 使用GRADE和CiNeMA方法评估证据确定性.
主要成果:
- 这个部分不适用,因为这是一个协议,不包含结果.
结论:
- 这个部分不适用,因为这是一个协议,不包含结果.
相关概念视频
Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Drug Therapy
245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
245
Antipsychotic Drugs: Therapeutic Uses and Side Effects
753
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
753
Psychosis: Goals of Pharmacotherapy
474
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
474
Antipsychotic Drugs: Typical and Atypical Agents
762
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
762

